PAMU
SPRY icon

Pictet Asset Management (UK)’s ARS Pharmaceuticals SPRY Stock Holding History

Pictet Asset Management (UK)’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$2.32M Sell
75,201
-3,147
-4% -$101K ﹤0.01% 986
2021
Q1 		$3.42M Sell
78,348
-46,652
-37% -$2.21M ﹤0.01% 911
2020
Q4 		$5.79M Buy
+125,000
New +$4.17M 0.01% 781

Other funds holding SPRY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pictet Asset Management (UK)'s SPRY Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its ARS Pharmaceuticals (SPRY) stake by 4% in Q2 2021, selling an estimated $101K and leaving 75,201 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #986.

Pictet Asset Management (UK) first reported a position in SPRY in Q4 2020 and has held it in 3 quarters since. The position peaked at $5.79M in Q4 2020. 76 funds tracked by Wall St. Rank hold SPRY as of Q2 2021.

  • Pictet Asset Management (UK) held 75,201 shares of ARS Pharmaceuticals worth $2.32M as of Q2 2021.
  • Pictet Asset Management (UK) sold 3,147 ARS Pharmaceuticals shares in Q2 2021, an estimated $101K.
  • ARS Pharmaceuticals made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #986 holding.
  • Pictet Asset Management (UK) first reported a position in ARS Pharmaceuticals in Q4 2020 and has held it in 3 quarters since.
  • Pictet Asset Management (UK)'s ARS Pharmaceuticals position peaked at $5.79M in Q4 2020.
  • 76 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.